Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-04-01 Troendle August J. Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2015-04-01 LAWLIS V BRYAN Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2015-04-01 LAWLIS V BRYAN Director Grant or award · Stock Option (Right to Buy) +6,250 6,250
2015-04-01 LAWLIS V BRYAN Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2015-04-01 HEALY JAMES Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2015-04-01 HEALY JAMES Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2015-04-01 Richards Christos Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2015-04-01 Wahlstrom Mats Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2015-04-01 Wahlstrom Mats Director Grant or award · Stock Option (Right to Buy) +75,000 75,000
2015-04-01 Satvat Ali J. Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2015-04-01 Szela Mary T Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2015-04-01 Richards Christos Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2015-04-01 Szela Mary T Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2015-04-01 Satvat Ali J. Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2015-04-01 LAWLIS V BRYAN Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2015-04-01 LAWLIS V BRYAN Director Grant or award · Stock Option (Right to Buy) +6,250 6,250
2015-04-01 LAWLIS V BRYAN Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2015-04-01 Herman Alan C. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2015-04-01 Wahlstrom Mats Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2015-04-01 Wahlstrom Mats Director Grant or award · Stock Option (Right to Buy) +75,000 75,000

Page 33 of 39 · 768 trades